基本信息
浏览量:0
职业迁徙
个人简介
Dr. Sokolow has a broad background in pharmacology and neurobiology of Alzheimer’s disease (AD), with specific training and expertise in molecular biology, clinical pharmacy and pharmacogenomics with emphasis in analyzing secondary data of drug response in the treatment of cognitive symptoms of AD and mild cognitive impairment (MCI). Her research program examines two main area of Alzheimer’s Disease (AD): 1) the molecular pathogenesis of AD in surviving nerve terminals and 2) the influence of genetics on the response to therapy in AD and mild cognitive impairment (MCI). Her current research project focuses on the discovery of genetic polymorphisms associated with response to AD medications, such as donepezil and other acetylcholinesterase inhibitors. Her early studies aimed at understanding the molecular repercussion of intrasynaptic amyloid-beta buildup in the development of AD. This includes studies investigating the role of intrasynaptic amyloid-beta and tau on glutamate and calcium signaling pathways (e.g. sodium-calcium exchange). Areas of Scholarly Expertise and Interest: Alzheimer’s disease, genetics, pharmacogenomics, pharmacology and therapeutics, biomarkers, calcium signaling pathways.
Research: Alzheimer’s disease, genetics, pharmacogenomics, biomarkers, calcium signaling pathways. Clinical: , clinical pharmacy, pharmacovigilance and pharmacosurveillance.
Research: Alzheimer’s disease, genetics, pharmacogenomics, biomarkers, calcium signaling pathways. Clinical: , clinical pharmacy, pharmacovigilance and pharmacosurveillance.
研究兴趣
论文共 47 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Neuronno. 16 (2022): 2571-2587.e13
Alzheimer's & dementia (New York, N. Y.)no. 1 (2021): e12168-e12168
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn